South African pharmaceutical company Aspen Pharmacare announced on Monday, December 29th, the sale of its main Asia-Pacific operations (excluding China) to Australian private equity fund BGH Capital for 2.37 billion Australian dollars, approximately 1.59 billion US dollars. This transaction, which includes markets in Australia, New Zealand, Hong Kong, Taiwan, Malaysia, and the Philippines, is part…...
Trending
- A Timeless Critique of Sartre: “A Plea for Intellectuals”
- EBID welcomes AfDB as its first institutional shareholder
- Algeria removed from the FATF grey list: a major turning point for the country’s financial credibility
- Senegal raises 107 billion CFA francs after strong demand from UEMOA investors
- Ivory Coast reaffirms itself two notches away from investment grade (Fitch)
- Senegal: hidden debt, undeclared debt, odious debt: what should be remembered?
- Insurance: 30% decrease in the consolidated profit of the Tunisian group CARTE in 2025
- Mounir Bensalah takes the reins of Colas Rail Morocco
South African Aspen Pharmacare sells key Asia-Pacific operations for $1.6 billion
By Félix NZALÉ
Félix NZALÉ
Félix Nzalé is a Senegalese journalist with a deep passion for cultural issues. He led the "CULTURE" section of SUD QUOTIDIEN (SUD Communication Group) for 10 years. Holder of dual Master’s degrees in Sociology and Philosophy, he also holds a management diploma from the Institut Supérieur de Management (ISM) in Dakar. He has contributed to the development of editorial concepts for several newspapers in Dakar.
Add A Comment
About us
Headed by Adama Wade and his team of 20 journalists, Kapital Afrik offers strategic and financial information to executives and managers. The aim of Kapital Afrik is to provide financial and political news, give priority to human entrepreneurial experiences, lend life to economic policies, give meaning to statistics….
Contact us: redaction@financialafrik.com